Kornitzer Capital Management Inc Dynavax Technologies Corp Transaction History

Kornitzer Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$2.27 - $6.2 $116,905 - $319,300	-51,500 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$11.85 - $16.0 $193,155 - $260,800	16,300 Added 46.31%	51,500 $639,000
Q2 2018 Aug 02, 2018	BUY	$15.15 - $20.75 $198,465 - $271,825	13,100 Added 59.28%	35,200 $537,000
Q4 2017 Jan 31, 2018	SELL	$17.3 - $24.08 $18.9 Million - $26.3 Million	-1,091,645 Reduced 98.02%	22,100 $413,000
Q3 2017 Oct 31, 2017	BUY	$15.2 - $21.5 $16.9 Million - $23.9 Million	1,113,745	1,113,745 $23.9 Million

276

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.62B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Kornitzer Capital Management Inc with notifications on news.